Nabi Biopharmaceuticals Announces Third Quarter 2008 Financial Results
06. November 2008 16:05 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the three month period ended September 27, 2008. The...
Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study
29. Oktober 2008 09:25 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive final results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...
Nabi Biopharmaceuticals to Announce Third Quarter Financial Results On November 6, 2008
27. Oktober 2008 15:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its third quarter 2008 financial results on Thursday, November 6, 2008,...
Nabi Biopharmaceuticals and NIAID to Advance PentaStaph Vaccine Research
09. September 2008 08:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the National Institute of Allergy and Infectious Diseases (NIAID), one of the National...
Nabi Biopharmaceuticals Announces Second Quarter 2008 Financial Results
07. August 2008 16:05 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 7, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three month period ended June 28, 2008. The Company...
Nabi Biopharmaceuticals Announces Arbitration Settlement With Inhibitex, Inc.
04. August 2008 16:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 4, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today a settlement of an arbitration proceeding against Inhibitex, Inc., effective August 1, 2008....
Nabi Biopharmaceuticals to Announce Second Quarter Financial Results On August 7, 2008
29. Juli 2008 09:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 29, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its second quarter 2008 financial results on Thursday, August 7, 2008, after...
Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
23. Juli 2008 09:15 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 23, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive interim results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...
Nabi Biopharmaceuticals Announces Receipt of $2.5 Million Milestone Payment
03. Juni 2008 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., June 3, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) has received a $2.5 million payment from Fresenius USA Manufacturing, Inc. (Fresenius) for the successful...
Nabi Biopharmaceuticals Announces First Quarter 2008 Financial Results
08. Mai 2008 16:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., May 8, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 29, 2008. The Company...